Molecular mechanisms that underpin EML4-ALK driven cancers and their response to targeted drugs
Crossref DOI link: https://doi.org/10.1007/s00018-015-2117-6
Published Online: 2016-01-11
Published Print: 2016-03
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Bayliss, Richard
Choi, Jene
Fennell, Dean A.
Fry, Andrew M.
Richards, Mark W.
Funding for this research was provided by:
Cancer Research UK (C24461/A12772)
Worldwide Cancer Research (13-0042)
License valid from 2016-01-11